WEKO3
アイテム
{"_buckets": {"deposit": "2d241228-2083-4eb6-99ae-56e01bde8d6a"}, "_deposit": {"created_by": 1, "id": "47044", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "47044"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00047044", "sets": ["1"]}, "author_link": ["469756", "469740", "469741", "469748", "469750", "469753", "469752", "469742", "469754", "469755", "469744", "469746", "469739", "469747", "469751", "469745", "469743", "469749"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2014-09", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "5", "bibliographicPageEnd": "958", "bibliographicPageStart": "948", "bibliographicVolumeNumber": "55", "bibliographic_titles": [{"bibliographic_title": "Journal of radiation research"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Amplitude-based gating aids treatment planning in scanned particle therapy because it gives better control of uncertainty with the gate window. We have installed an X-ray fluoroscopic imaging system in our treatment room for clinical use with an amplitude-based gating strategy. We evaluated the effects of this gating under realistic organ motion conditions using 4 DCT data of lung and liver tumors. 4 DCT imaging was done for 24 lung and liver patients using the area-detector CT. We calculated the field-specific target volume (FTV) for the gating window, which was defined for a single respiratory cycle. Prescribed doses of 48 Gy relative biological effectiveness (RBE)/fraction/four fields and 45 Gy RBE/two fractions/two fields were delivered to the FTVs for lung and liver treatments, respectively. Dose distributions were calculated for the repeated first respiratory cycle (= planning dose) and the whole respiratory data (= treatment dose). We applied eight phase-controlled rescannings with the amplitude-based gating. For the lung cases, D95 of the treatment dose (= 96.0 ± 1.0%) was almost the same as that of the planning dose (= 96.6 ± 0.9%). D(max)/D(min) of the treatment dose (= 104.5 ± 2.2%/89.4 ± 2.6%) was slightly increased over that of the planning dose (= 102.1 ± 1.0%/89.8 ± 2.5%) due to hot spots. For the liver cases, D95 of the treatment dose (= 97.6 ± 0.5%) was decreased by ∼ 1% when compared with the planning dose (= 98.5 ± 0.4%). D(max)/D(min) of the treatment dose was degraded by 3.0%/0.4% compared with the planning dose. Average treatment times were extended by 46.5 s and 65.9 s from those of the planning dose for lung and liver cases, respectively. As with regular respiratory patterns, amplitude-based gated multiple phase-controlled rescanning preserves target coverage to a moving target under irregular respiratory patterns.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Oxford University Press"}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "24835238", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1093/jrr/rru032", "subitem_relation_type_select": "DOI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0449-3060", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Mori, Shinichiro"}], "nameIdentifiers": [{"nameIdentifier": "469739", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Inaniwa, Taku"}], "nameIdentifiers": [{"nameIdentifier": "469740", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Furukawa, Takuji"}], "nameIdentifiers": [{"nameIdentifier": "469741", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takahashi, Wataru"}], "nameIdentifiers": [{"nameIdentifier": "469742", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakajima, Mio"}], "nameIdentifiers": [{"nameIdentifier": "469743", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shirai, Toshiyuki"}], "nameIdentifiers": [{"nameIdentifier": "469744", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Noda, Koji"}], "nameIdentifiers": [{"nameIdentifier": "469745", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yasuda, Shigeo"}], "nameIdentifiers": [{"nameIdentifier": "469746", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamamoto, Naoyoshi"}], "nameIdentifiers": [{"nameIdentifier": "469747", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "森 慎一郎", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "469748", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "稲庭 拓", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "469749", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "古川 卓司", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "469750", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "高橋 渉", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "469751", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "中嶋 美緒", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "469752", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "白井 敏之", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "469753", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "野田 耕司", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "469754", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "安田 茂雄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "469755", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山本 直敬", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "469756", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Amplitude-based gated phase-controlled rescanning in carbon-ion scanning beam treatment planning under irregular breathing conditions using lung and liver 4DCTs.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Amplitude-based gated phase-controlled rescanning in carbon-ion scanning beam treatment planning under irregular breathing conditions using lung and liver 4DCTs."}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/47044", "pubdate": {"attribute_name": "公開日", "attribute_value": "2015-03-19"}, "publish_date": "2015-03-19", "publish_status": "0", "recid": "47044", "relation": {}, "relation_version_is_last": true, "title": ["Amplitude-based gated phase-controlled rescanning in carbon-ion scanning beam treatment planning under irregular breathing conditions using lung and liver 4DCTs."], "weko_shared_id": -1}
Amplitude-based gated phase-controlled rescanning in carbon-ion scanning beam treatment planning under irregular breathing conditions using lung and liver 4DCTs.
https://repo.qst.go.jp/records/47044
https://repo.qst.go.jp/records/47044d9cd916a-cee6-4321-bc66-24cd6be6e34f
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2015-03-19 | |||||
タイトル | ||||||
タイトル | Amplitude-based gated phase-controlled rescanning in carbon-ion scanning beam treatment planning under irregular breathing conditions using lung and liver 4DCTs. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Mori, Shinichiro
× Mori, Shinichiro× Inaniwa, Taku× Furukawa, Takuji× Takahashi, Wataru× Nakajima, Mio× Shirai, Toshiyuki× Noda, Koji× Yasuda, Shigeo× Yamamoto, Naoyoshi× 森 慎一郎× 稲庭 拓× 古川 卓司× 高橋 渉× 中嶋 美緒× 白井 敏之× 野田 耕司× 安田 茂雄× 山本 直敬 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Amplitude-based gating aids treatment planning in scanned particle therapy because it gives better control of uncertainty with the gate window. We have installed an X-ray fluoroscopic imaging system in our treatment room for clinical use with an amplitude-based gating strategy. We evaluated the effects of this gating under realistic organ motion conditions using 4 DCT data of lung and liver tumors. 4 DCT imaging was done for 24 lung and liver patients using the area-detector CT. We calculated the field-specific target volume (FTV) for the gating window, which was defined for a single respiratory cycle. Prescribed doses of 48 Gy relative biological effectiveness (RBE)/fraction/four fields and 45 Gy RBE/two fractions/two fields were delivered to the FTVs for lung and liver treatments, respectively. Dose distributions were calculated for the repeated first respiratory cycle (= planning dose) and the whole respiratory data (= treatment dose). We applied eight phase-controlled rescannings with the amplitude-based gating. For the lung cases, D95 of the treatment dose (= 96.0 ± 1.0%) was almost the same as that of the planning dose (= 96.6 ± 0.9%). D(max)/D(min) of the treatment dose (= 104.5 ± 2.2%/89.4 ± 2.6%) was slightly increased over that of the planning dose (= 102.1 ± 1.0%/89.8 ± 2.5%) due to hot spots. For the liver cases, D95 of the treatment dose (= 97.6 ± 0.5%) was decreased by ∼ 1% when compared with the planning dose (= 98.5 ± 0.4%). D(max)/D(min) of the treatment dose was degraded by 3.0%/0.4% compared with the planning dose. Average treatment times were extended by 46.5 s and 65.9 s from those of the planning dose for lung and liver cases, respectively. As with regular respiratory patterns, amplitude-based gated multiple phase-controlled rescanning preserves target coverage to a moving target under irregular respiratory patterns. | |||||
書誌情報 |
Journal of radiation research 巻 55, 号 5, p. 948-958, 発行日 2014-09 |
|||||
出版者 | ||||||
出版者 | Oxford University Press | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0449-3060 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 24835238 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1093/jrr/rru032 |